Immuron Ltd. Files 6-K, Reports One Announcement
Ticker: IMRN · Form: 6-K · Filed: Sep 9, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Sep 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, disclosure, foreign-private-issuer
TL;DR
Immuron Ltd. filed a 6-K saying they made an announcement, but didn't say what it was.
AI Summary
On September 9, 2024, Immuron Ltd. filed a Form 6-K to report that it published one announcement during the month of September 2024. The filing itself does not contain the details of the announcement, only that one was made.
Why It Matters
This filing indicates Immuron Ltd. has made a public disclosure, but the content of that disclosure is not provided in this specific document, requiring further investigation for investors.
Risk Assessment
Risk Level: low — This is a routine filing indicating an announcement was made, but the content of the announcement is not detailed within this specific 6-K.
Key Players & Entities
- Immuron Ltd. (company) — Registrant
- 001-38104 (other) — Commission File Number
- September 2024 (date) — Reporting period for announcement
FAQ
What was the announcement published by Immuron Ltd. in September 2024?
The Form 6-K filing does not specify the content of the announcement made by Immuron Ltd. in September 2024.
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information which the issuer has made or is required to make public pursuant to the laws of its home country or the laws of the country of its incorporation, or which it has made or is required to make public pursuant to the rules of any stock exchange on which its securities are traded.
What is Immuron Ltd.'s principal executive office address?
Immuron Ltd.'s principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Immuron Ltd. file annual reports under Form 20-F?
Yes, Immuron Ltd. indicates it files annual reports under cover of Form 20-F.
Is Immuron Ltd. furnishing information to the SEC pursuant to Rule 12g3-2(b)?
No, Immuron Ltd. is not furnishing information to the SEC pursuant to Rule 12g3-2(b), as indicated by the 'No' checkbox being marked.
Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 18.7 · Accepted 2024-09-09 08:00:19
Filing Documents
- ea0213014-6k_immuron.htm (6-K) — 12KB
- ea021301401ex99-1_immuron.htm (EX-99.1) — 317KB
- ex99-1_001.jpg (GRAPHIC) — 163KB
- ex99-1_002.jpg (GRAPHIC) — 167KB
- 0001213900-24-076714.txt ( ) — 785KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on August 30, 2024 titled: - “Appendix 4E and Preliminary Final Report” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Appendix 4E and Preliminary Final Report 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: September 9, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3